Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

912
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

390
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

222
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Decreasing Function01:27

Decreasing Function

220
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
220
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

342
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

606
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiographic Evaluation of Coronary Microvascular Dysfunction and Biventricular Mechanics in Behçet's Disease: The Additive Value of Coronary Sinus Flow Index.

Echocardiography (Mount Kisco, N.Y.)·2026
Same author

Sex-Specific Heart Rate Variability Associations With Vitamin B12, Folate, and Iron Status.

Reviews in cardiovascular medicine·2026
Same author

Association between Hashimoto's thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort study.

Postgraduate medicine·2026
Same author

Geometric Morphometrics Reveals That Alfacalcidol, but Not Cholecalciferol, Preserves Renal Corpuscle Architecture in Rheumatoid Arthritis in Rats.

International journal of molecular sciences·2026
Same author

Systemic inflammatory markers and epicardial fat volume as predictors of cardiometabolic risk in type 2 diabetes.

Postgraduate medical journal·2025
Same author

Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study).

Journal of clinical medicine·2025

Related Experiment Video

Updated: Jan 22, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.2K

Does Mean Platelet Volume Decrease in the presence of Coronary Artery Fistula?

Isa Sincer1, Yusuf Çekici2, Mehmet Cosgun1

  • 1Abant Izzet Baysal University Hospital, Bolu - Turkey.

Arquivos Brasileiros De Cardiologia
|July 5, 2019
PubMed
Summary

Mean platelet volume (MPV) may be a useful indicator for coronary artery fistula (CAF). This study found lower MPV levels in patients with CAF, suggesting a potential diagnostic marker for this condition.

More Related Videos

Modified Technique for Coronary Artery Ligation in Mice
05:47

Modified Technique for Coronary Artery Ligation in Mice

Published on: March 29, 2013

26.5K
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

22.1K

Related Experiment Videos

Last Updated: Jan 22, 2026

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.2K
Modified Technique for Coronary Artery Ligation in Mice
05:47

Modified Technique for Coronary Artery Ligation in Mice

Published on: March 29, 2013

26.5K
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

22.1K

Area of Science:

  • Cardiology
  • Hematology
  • Medical Diagnostics

Background:

  • Coronary artery fistula (CAF) is an abnormal vascular connection.
  • Mean platelet volume (MPV) is linked to cardiovascular diseases.
  • No prior studies explored hematologic parameters in congenital CAF.

Purpose of the Study:

  • To investigate the association between MPV and congenital CAF.
  • To determine if MPV can serve as a predictor for CAF.

Main Methods:

  • Compared MPV levels in 50 CAF patients versus 70 controls.
  • Utilized routine blood tests and biochemical parameters.
  • Employed t-test, Mann-Whitney test, regression, and Pearson's correlation analyses.

Main Results:

  • CAF patients exhibited significantly lower MPV levels (p < 0.001).
  • MPV was a significant independent predictor of CAF (p < 0.001).
  • An MPV cutoff of < 9.6 fL demonstrated 80% sensitivity and 68% specificity for CAF prediction.

Conclusions:

  • MPV levels are decreased in patients with CAF.
  • MPV may serve as a potential diagnostic biomarker for CAF.